Pharma companies still fail to embrace social media

As the pharmaceutical industry awaits social media guidance from the FDA, drug makers have avoided involvement over regulatory fears

Although social media use in healthcare continues to grow, a new study has found that about half of the top 50 pharmaceutical companies are not actively engaging with patients through social media and the same amount of companies are not using social media effectively.  More specifically, as drug makers experiment with social media to engage consumers, they are reluctant to use these tools to bolster their efforts in designing and developing clinical trials.

According to the study, “Engaging Patients Through Social Media” by the IMS Institute for Healthcare Informatics, while only one in 10 clinical trials run by drug makers have recruited participants through social media channels, most have yet to try it. Concerns range from protecting patient privacy to equally sticky issues such as patients who publicly distort event experiences or introduce research bias by sharing treatment information with others.

Contributing Author

author image

Amanda Ciccatelli

Amanda G. Ciccatelli is a Contributing Writer for InsideCounsel, where she covers the patent litigation space. Amanda earned a B.A. in Communications and Journalism from...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.